GYRE earnings: a negative outcome, -41.8%

On November 12, 2021, GYRE THERAPEUTICS, INC. reached its earnings. The result was a negative outcome, and the stock moved -41.8% in the window around the event. It had already run -25.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.